TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene? Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
Targeting New Pathways to Improve Outcomes in Renal Cell Carcinoma Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinoma Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients Nov 11, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
Transitioning Cancer Survivors Away From Oncologic Care It's time for a new model of care Nov 03, 2023
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
Randomized Trial Backs HIF-2a Inhibition in Advanced RCC After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancer Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train? It's time for clear guidelines Oct 18, 2023
Single Dose of Antibiotic Cured Early Syphilis, Even in Those With HIV One dose proved noninferior to triple-dose regimen in randomized trial Oct 16, 2023
Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBC Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
FDA OKs Another Injectable for Rare Kidney Disorder Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
Global Incidence of Early-Onset Cancer Has Surged Since 1990 Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
Prostate Cancer Is Not Just an 'Old Man's Disease' Spreading this message can save lives Sep 02, 2023
Testosterone Loss in Older Men: Factors Beyond Age in the Mix Several lifestyle, health factors associated with declining levels Aug 28, 2023
Does Cancer Screening Actually Extend Lives? A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
Gender Affirming Surgeries Nearly Tripled in the U.S. From 2016 to 2019 Breast and chest procedures most common, followed by genital reconstruction Aug 25, 2023
FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinence Three-fourths of patients had 50% reduction in incontinence at 6 months, 82% at 12 months Aug 18, 2023
Older Surgical Procedure for Pelvic Prolapse Repair Prevails in Randomized Trial Another study showed vaginal estrogen during prolapse repair did not affect surgical outcomes Aug 17, 2023
'Conscience' Bills Let Medical Providers Opt Out of Providing a Wide Range of Care Protections for health workers may reduce standard of care, opponents say Aug 06, 2023
Sugar-Heavy Diet Linked to Development of Kidney Stones Those who consumed 25% or more of their daily calories from added sugars had the highest odds Aug 04, 2023
Multi-Cancer Early Detection: 20th-Century Fiction Becomes Reality These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
Adjuvant Everolimus Falls Short in High-Risk Renal Cancer However, the drug did show benefit in a subgroup at highest risk of recurrence after nephrectomy Jul 31, 2023
The Wild West of Online Testosterone Prescribing Online "low T" clinics thrived during the pandemic, but changing rules could bring them down Jul 28, 2023
MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
Circumcision May Be Protective Against HIV in Men Who Have Sex With Men Voluntary medical procedure offers another option for prevention Jul 20, 2023
COVID-19 Impaired Fertility Treatments IVF and sperm injections less effective after infection, Chinese researchers say Jul 13, 2023
Postoperative Urinary Retention Common After Hernia Surgery Incidence reaches nearly one in 10 in older men Jul 06, 2023
EphrinB2 Expression in Urothelial Cancer Tied to Checkpoint Inhibitor Activity Retrospective data confirm EphrinB2 as a negative prognostic marker Jul 05, 2023 video
COVID Infection May Impair Semen Quality, Even After Mild Cases Jury still out on whether infection can cause permanent seminal damage, however Jun 30, 2023
Agent Orange Exposure Tied to Bladder Cancer Risk in Veterans Increased risk described as "modest," and no association seen with aggressiveness of cancer Jun 27, 2023
